PET-CT with intravenous contrast in the evaluation of patients with lymphoma. Contribution to diagnostic indications;PET-TAC con contraste intravenoso en la valoración de pacientes con linfoma. Aproximación hacia las indicaciones diagnósticas

Revista Espanola de Medicina Nuclear

Volumn 28, Issue 5, 2009, Pages 235-241

  Talavera Rubio, M P ^a   Garcia Vicente A M ^a   Dominguez Ferreras E ^a   Calle Primo, C ^a   Poblete Garcia V M ^a   Hernandez Ruiz B ^a   Bellon Guardia M ^a   Palomar Munoz A ^a   Cepedello Boiso, I ^a   Pilkington Woll, P ^a   Gonzalez Garcia B ^a   Cordero Garcia J M ^a   Molino Trinidad, C ^a   Soriano Castrejon A ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE CIUDAD REAL   (Spain)

Author keywords

Intravenous contrast; Lymphoma; PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOHEXOL;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL EXAMINATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; PROSPECTIVE STUDY; RELIABILITY; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TUMOR RECURRENCE; TUMOR REGRESSION;

EID: 70149097081     PISSN: 02126982     EISSN: 1578200X     Source Type: Journal    
DOI: 10.1016/S1578-200X(09)70024-5     Document Type: Article

References (22)

1. Schaefer N.G., Hany T.F., Taverna C., Seifert B., Stumpe K.D., von Schulthess G.K., et al. Non-Hodgkin lymphoma and Hodgkin disease: Coregistered FDG PET and CT at staging and restaging-do we need contrast-enhanced CT?. Radiology 232 (2004) 823-829
2. Allen-Auerbach M., Quon A., and Weber W.A. Comparison between 18-f fdg pet and pet-tc hardware fusion for staging of patients with lymphoma. Mol Imaging Boil 6 (2004) 411-416
3. Pelosi E., Pregno P., Penna D., Deandreis D., Chiappella A., Limerutti G., et al. Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma. Radiol Med (Torino) 113 (2008) 578-590
4. Rodríguez-Vigil B., Gómez-León N., Pinilla I., Hernández-Maraver D., Coya J., Martín-Curto L., et al. PET/CT in lymphoma: Prospective study of enhanced full-dose PET/CT versus unenhanced low-dose PET/CT. J Nucl Med 47 (2006) 1643-1648
5. Tatsumi M., Conade C., Nakamoto Y., Fishman E.K., and Wahl R.L. Direct comparison of FDG and CT findings in patients with lymphoma: Initial experience. Radiology 237 (2005) 1038-1045
6. Hernández-Maraver D., Hernández-Navarro F., Gómez-León N., Coya J., Rodríguez-Vigil B., Madero R., et al. Pet/ct: Diagnostic accuracy in lymphoma. British J Haematol 135 (2006) 293-302
7. Juweid M.E., Stroobants S., Hoekstra O.S., Mottaghy F.M., Dietlein M., Guermazi, et al. Use of positron emission tomography for response assessment of lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 25 (2007) 57
8. Cortés-Funes H. Aportación de la PET-TAC en decisiones diagnóstico-terapéuticas en Oncología Médica. Rev Esp Med Nucl 27 (2008) 79-82
9. Cuenca Cuenca J.L., Borrego Dorado I., Vázquez Albertino R., Gómez Camarero P., Sanz Viedma S., and Fernández López R. Impacto clínico de la PET-FDG en pacientes con sospecha de recurrencia de cáncer de ovario. Rev Esp Med Nucl 27 (2008) 411-417
10. Banzo I., Quince R., Mártinez-Rodríguez I., Jiménez-Bonilla J.F., Saínz-Esteban A., Barragán J., et al. La PET/TAC con 18F-FDG en la evaluación de la respuesta de los tumores del estroma gastrointestinal al tratamiento con imatinib. Rev Esp Med Nucl 27 (2008) 168-175
11. Cabrera Martín M.N., Pasamontes Pingaron J.A., Carreras Delgado J.L., Lapeña Gutiérrez L., Delgado Bolton R.C., Bittini Copano A., et al. Eficacia diagnóstica de la PET 18F-FDG en el cáncer diferenciado de tiroides residual o recurrente con tiroglobulina elevada y rastreo con 131-I negativo. Rev Esp Med Nucl 26 (2007) 263-269
12. Gill S., Wolf M., Prince H.M., Januszewicz H., Ritchie D., Hicks R.J., et al. [18F] fluorodeoxyglucose positron emission tomography scanning for staging, response assessment, and disease surveillance in patients with mantle cell lymphoma. Clin Lymphoma Myeloma 8 (2008) 159-165
13. Raanani P., Shasha Y., Perry C., Metser U., Naparstek E., Apter S., et al. Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era?. Ann Oncol 17 (2006) 117-122
14. Kwee T.C., Kwee R.M., and Nievelstein R.A. Imaging in staging of malignant lymphoma: A systematic review. Blood 111 (2008) 504-516
15. Morimoto T., Tateishi U., Maeda T., Arai Y., Nakajima Y., and Edmund Kim E. Nodal status of malignant lymphoma in pelvic and retroperitoneal lymphatic pathways: Comparison of integrated PET/CT with or without contrast enhancement. Eur J Radiol 67 (2008) 508-513
16. La Fougère C., Pfluger T., Schneider V., Hacker M., Bröckel N., Morhard D., et al. Restaging of patients with lymphoma. Comparison of low dose CT (20 mAs) with contrast enhanced diagnostic CT in combined [18F]-FDG PET/CT. Nuklearmedizin 47 (2008) 37-42
17. Moulin-Romsee G., and Mortelmans L. PET versus PET-CT in patient with suspicion of non-Hodgkin lymphoma recurrence. Clin Nucl Med 32 (2007) 954-955
18. Tsamita C.S., Golemi A., Egesta L., Castellucci P., Nanni C., Stefoni V., et al. Clinical significance of axillary findings in patients with lymphoma during follow-up with 18F-fluorodeoxyglucose-PET. Nucl Med Commun 29 (2008) 705-710
19. Karam M., Roberts-Klein S., Shet N., Chang J., and Feustel P. Bilateral hilar foci on 18F-FDG PET scan in patients without lung cancer: Variables associated with benign and malignant etiology. J Nucl Med 49 (2008) 1429-1436
20. Kobe C., Dietlein M., Franklin J., Markova J., Lohri A., Amthauer H., et al. Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first line chemotherapy in advanced-stage Hodgkin lymphoma. Blood 112 (2008) 3989-3994
21. Focosi D., Caracciolo F., Galimberti S., Papineschi F., and Petrini M. False positive PET scanning caused by inactivated influenza virus vaccination during complete remission from anaplastic T-cell lymphoma. Ann Hematol 87 (2008) 343-344
22. Lustberg M.B., Aras O., and Meisenberg B.R. FDG PET/CT findings in acute adult mononucleosis mimicking malignant lymphoma. Eur J Haematol 81 (2008) 154-156